|
XB-GENEPAGE-1008042
Papers associated with slc16a5
???pagination.result.count???
???pagination.result.page??? 1
Sort Newest To Oldest | Sort Oldest To Newest |
Contribution of Monocarboxylate Transporter 6 to the Pharmacokinetics and Pharmacodynamics of Bumetanide in Mice., Jones RS, Ruszaj D, Parker MD, Morris ME., Drug Metab Dispos. September 1, 2020; 48 (9): 788-795. |
|
Identification of a selective inhibitor of human monocarboxylate transporter 4., Futagi Y, Kobayashi M, Narumi K, Furugen A, Iseki K., Biochem Biophys Res Commun. January 1, 2018; 495 (1): 427-432. |
|
Characterization of monocarboxylate transporter 6: expression in human intestine and transport of the antidiabetic drug nateglinide., Kohyama N, Shiokawa H, Ohbayashi M, Kobayashi Y, Yamamoto T., Drug Metab Dispos. November 1, 2013; 41 (11): 1883-7. |
|
Functional characterization of human monocarboxylate transporter 6 (SLC16A5)., Murakami Y, Kohyama N, Kobayashi Y, Ohbayashi M, Ohtani H, Sawada Y, Yamamoto T., Drug Metab Dispos. December 1, 2005; 33 (12): 1845-51. |
???pagination.result.page??? 1